Assessing Current Treatment Options for Patients With Severe/Advanced Basal Cell Carcinoma

Seminars in Cutaneous Medicine and Surgery

Volumn 30, Issue 4 SUPPL., 2011, Pages

  Weinstock, Martin A ^a   Still, Joanne M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Basal cell carcinoma; Basal cell nevus syndrome; Chemoprevention; Gorlin syndrome; Nevoid basal cell carcinoma; Treatment

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CLINICAL ASSESSMENT; CRYOSURGERY; DISEASE SEVERITY; GENODERMATOSIS; SKIN CANCER;

BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; HUMANS; SKIN NEOPLASMS;

EID: 83655193541     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2011.11.004     Document Type: Article

References (7)

1. Basal Cell and Squamous Cell Skin Cancers, Version 1.2012 National Comprehensive Cancer Network, Accessed October 20, 2011. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
2. Cockerell C.J., Tran K.T., Carucci J., et al. Basal cell carcinoma. Cancer of the Skin 2011, 99-122. Elsevier/Saunders, St Louis, MO, chap 11. ed 2. D.S. Rigel, J.K. Robinson, M. Ross (Eds.).
3. Spiller W.F., Spiller R.F. Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 1984, 11:808-814.
4. Gulleth Y., Goldberg N., Silverman R.P., et al. What is the best surgical margin for a basal cell carcinoma: A meta-analysis of the literature. Plast Reconstr Surg 2010, 126:1222-1231.
5. Blume J.E., Oseroff A.R. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin 2007, 25:5-14.
6. Klein E., Stoll H.L., Miller E., et al. The effects of 5-fluorouracil (5-FU) ointment in the treatment of neoplastic dermatoses. Dermatologica 1970, 140(suppl):21-33.
7. Geisse J., Caro I., Lindholm J., et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004, 50(5):722-733.